greeksoup/ stock research
Stock research / United States / Funds / Knott David M Jr

Knott David M Jr

CIK 1892770 · latest 13F filed 12 August 2026 · Read the filing on EDGAR

Knott David M Jr reported 84 US-listed holdings worth $189.2 million in its 13F for the quarter ended 30 June 2026, filed 12 August 2026. Its largest: Alphabet Inc. (17.1%), Apollo Global Management, Inc. (14.1%) and Syndax Pharmaceuticals Inc. (5.1%). Against the quarter before, it opened 11 positions, added to 16, trimmed 4 and sold out of 12.

Reported holdings$189.2M+12.6% on Q1 2026
Positions84-1 on Q1 2026
The largest ten62.8%of its reported holdings
Latest 13FQ2 2026filed 12 August 2026
Where the money is
Added toHeldTrimmed
GOOG17.1%APO14.1%SNDX5.1%XERS4.4%TVTX4.4%PTGX4.1%BBIO3.7%IOVA3.5%ALKS3.4%JPM3.1%JAAA2.5%LPL2.5%COGT2.3%TGTX70 more28.0%

The 14 largest of its 84 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $284.6 million in 92 positions$285MQ3 24Q4 2024: $276.5 million in 89 positions$277MQ4 24Q1 2025: $212.0 million in 84 positions$212MQ1 25Q2 2025: $220.6 million in 85 positions$221MQ2 25Q3 2025: $238.7 million in 87 positions$239MQ3 25Q4 2025: $215.9 million in 87 positions$216MQ4 25Q1 2026: $168.0 million in 85 positions$168MQ1 26Q2 2026: $189.2 million in 84 positions$189MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +62.2% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100120140160Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +62.2%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 11Added 16Held 53Trimmed 4Sold out 12
Opened: 11Added: 16Held: 53Trimmed: 4Sold out: 12

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 11

  1. Catalyst Bancorp Inc. CLST$3.6 million
  2. Spruce Biosciences Inc. SPRB$1.1 million
  3. DuPont de Nemours, Inc.$510,956
  4. Insmed Inc. INSM$453,455
  5. LB Pharmaceuticals Inc. LBRX$420,779
  6. Caredx Inc. CDNA$388,455
  7. Q32 Bio Inc. QTTB$387,449
  8. Enliven Therapeutics Inc. ELVN$313,787

and 3 more in the table below

Added to 16

  1. Cullinan Therapeutics Inc. CGEM+44,982 shares · +186%
  2. Madrigal Pharmaceuticals Inc. MDGL+1,000 shares · +50%
  3. Travere Therapeutics Inc. TVTX+6,649 shares · +5%
  4. Syndax Pharmaceuticals Inc. SNDX+15,245 shares · +4%
  5. Ardelyx Inc. ARDX+56,168 shares · +27%
  6. Cogent Biosciences Inc. COGT+7,081 shares · +7%
  7. Bridgebio Pharma Inc. BBIO+2,850 shares · +3%
  8. Verastem Inc. VSTM+51,000 shares · +49%

and 8 more in the table below

Trimmed 4

  1. TG Therapeutics, Inc. TGTX-23,162 shares · -26%
  2. Bristol-Myers Squibb Co. BMY-11,622 shares · -85%
  3. JPMorgan Chase & Co. JPM-1,379 shares · -7%
  4. Occidental Petroleum Corp. OXY-194 shares · -29%

Sold out of 12

  1. Catalyst Pharmaceuticals Inc. CPRX$3.0 million last quarter
  2. Arcellx Inc. ACLX$2.2 million last quarter
  3. Cytokinetics Inc. CYTK$1.6 million last quarter
  4. Centessa Pharmaceuticals PLC CNTA$1.5 million last quarter
  5. Adma Biologics, Inc. ADMA$542,402 last quarter
  6. Biohaven Pharmaceutical Holding Co. Ltd$513,691 last quarter
  7. Evolus Inc. EOLS$408,279 last quarter
  8. Lenz Therapeutics Inc. LENZ$308,648 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Alphabet Inc. GOOG91.4K$32.3 million17.07%no change
Apollo Global Management, Inc. APO225.0K$26.6 million14.07%no change
Syndax Pharmaceuticals Inc. SNDX437.2K$9.6 million5.05%+15.2K
Xeris Biopharma Holdings Inc. XERS1.1M$8.4 million4.44%no change
Travere Therapeutics Inc. TVTX147.3K$8.4 million4.42%+6.6K
Protagonist Therapeutics, Inc. PTGX63.0K$7.7 million4.08%no change
Bridgebio Pharma Inc. BBIO92.8K$6.9 million3.66%+2.9K
Iovance Biotherapeutics Inc. IOVA1.6M$6.7 million3.52%no change
Alkermes plc. ALKS121.8K$6.4 million3.37%+1.8K
JPMorgan Chase & Co. JPM18.1K$5.9 million3.13%-1.4K
Janus Detroit STR Trust JAAA93.5K$4.7 million2.50%no change
LPL Financial Holdings Inc.16.5K$4.6 million2.46%no change
Cogent Biosciences Inc. COGT111.1K$4.3 million2.27%+7.1K
TG Therapeutics, Inc. TGTX66.8K$3.7 million1.94%-23.2K
Catalyst Bancorp Inc. CLST114.0K$3.6 million1.89%new
Agios Pharmaceuticals Inc. AGIO95.1K$3.5 million1.86%+2.0K
Viridian Therapeutics Inc. VRDN181.0K$3.3 million1.76%no change
Relmada Therapeutics Inc. RLMD451.0K$3.1 million1.65%+11.7K
Arcus Biosciences, Inc. RCUS81.2K$2.5 million1.32%no change
Cybin Inc. HELP370.0K$2.4 million1.29%+20.0K
SPDR Ser Trust XBI15.0K$2.4 million1.25%no change
Rezolute Inc. RZLT370.0K$1.9 million1.02%no change
AllianceBernstein Holding LP AB48.0K$1.7 million0.89%no change
Madrigal Pharmaceuticals Inc. MDGL3.0K$1.6 million0.85%+1.0K
Atricure Inc. ATRC51.4K$1.4 million0.76%no change
Docgo Inc. DCGO2.7M$1.4 million0.73%no change
Ardelyx Inc. ARDX263.2K$1.3 million0.71%+56.2K
Ultragenyx Pharmaceutical in RARE38.1K$1.3 million0.67%+5.0K
Series Portfolios Trust CLOZ47.8K$1.3 million0.67%no change
Cullinan Therapeutics Inc. CGEM69.2K$1.3 million0.67%+45.0K
Johnson & Johnson JNJ4.9K$1.3 million0.66%no change
Vera Therapeutics Inc. VERA26.0K$1.1 million0.59%no change
Orchestra Biomed Holdings in OBIO253.7K$1.1 million0.58%no change
Spruce Biosciences Inc. SPRB20.0K$1.1 million0.57%new
Connect Biopharma Hldgs Ltd CNTB444.9K$1.1 million0.56%+57.0K
iShares Trust IBB5.5K$1.0 million0.55%no change
Biogen Inc. BIIB4.0K$864,2400.46%no change
Pfizer Inc. PFE32.3K$778,6750.41%no change
Apple Inc. AAPL2.5K$721,6640.38%no change
Canadian Natural Resources Limited CNQ16.8K$663,6000.35%no change
Pelthos Therapeutics Inc. PTHS22.1K$623,7830.33%+1.0K
International Business Machines Corp. IBM2.1K$602,3520.32%no change
Microsoft Corp. MSFT1.6K$596,8320.32%no change
Verastem Inc. VSTM155.0K$592,1000.31%+51.0K
Kura Oncology Inc. KURA52.8K$578,8540.31%no change
Solid Biosciences Inc. SLDB56.2K$561,5180.30%+9.1K
DuPont de Nemours, Inc.3.8K$510,9560.27%new
Insmed Inc. INSM4.3K$453,4550.24%new
LB Pharmaceuticals Inc. LBRX13.0K$420,7790.22%new
Caredx Inc. CDNA13.6K$388,4550.21%new
Q32 Bio Inc. QTTB30.4K$387,4490.20%new
Enliven Therapeutics Inc. ELVN6.2K$313,7870.17%new
Ryman Hospitality Properties, Inc. RHP2.4K$308,5200.16%no change
Broadcom Inc. AVGO710$268,2020.14%no change
Kimberly Clark Corp. KMB2.4K$263,4480.14%no change
NVIDIA Corp. NVDA1.3K$256,1150.14%no change
Boston Scientific Corp. BSX6.0K$256,0800.14%new
Wave Life Sciences Ltd WVE40.0K$232,4000.12%no change
Rain Enhancement Technologie RAIN101.7K$210,4900.11%no change
Mondelez International, Inc. MDLZ3.0K$173,5200.09%no change
Quanta Services, Inc. PWR176$126,7270.07%no change
Bristol-Myers Squibb Co. BMY2.0K$115,2400.06%-11.6K
Eastern Bankshares, Inc. EBC5.0K$111,2000.06%no change
Alphabet Inc. GOOGL300$107,2110.06%no change
Legacy Housing Corp. LEGH4.0K$105,0800.06%no change
Corteva, Inc. CTVA1.2K$102,1360.05%no change
iShares Russell Mid-Cap Growth ETF IWP695$101,7550.05%no change
United Rentals, Inc. URI78$88,3650.05%no change
Invivyd Inc. IVVD100.0K$87,2400.05%no change
Amazon.com Inc. AMZN300$71,5020.04%no change
Danaher Corp. DHR180$34,2860.02%no change
Dow Inc. DOW1.2K$32,9960.02%no change
FS KKR Cap Corp. FSK2.9K$30,1870.02%new
International Game Technolog BRSL2.5K$26,8000.01%no change
Blackstone Inc. BX210$24,7110.01%no change
UnitedHealth Group Inc. UNH57$23,6910.01%no change
Occidental Petroleum Corp. OXY469$22,7790.01%-194
Thermo Fisher Scientific Inc. TMO45$22,5610.01%no change
Salesforce, Inc. CRM77$12,0630.01%no change
Starwood Property Trust, Inc. STWD400$6,5520.00%no change
Kyndryl Holdings, Inc. KD428$4,8410.00%no change
Occidental Pete Corp.194$4,2680.00%new
GE HealthCare Technologies Inc. GEHC50$3,2000.00%no change
Westinghouse Air Brake Technologies Corp. WAB6$1,6180.00%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 12 it sold out of are in the box above.